Asanko is among the most undervalued gold stocks in the entire world; the combined company will have $280 million in cash and a $150 million debt facility for total available capital of $430 million. Did I mention the combined company would only have a market cap of $363 million?
- With a massive resource base of more than 7 million ounces of gold, the market is placing a value on each ounce of just $13! (Producer peers average more than $100 an ounce).
- In addition, management and insiders own approximately 12 percent of the company.
CASH value $2.18
book value higher
Any gold price decline shouldn't have much impact on its current stock price as CASH is CASH with no debt
any reversal of gold price should have POSITIVE impact on this stock price as it raises the profitability
All elements for a rally is here. The catalyst might be:
#1, hedge fund taking a position
#2, quarterly sales announcement(is we check back last CC, ceo was talking about the momentum in the business)
#3, Open to explore the sales of the company
#4,Business expanding to China
On December 20, 2013, James K. Malernee, Jr., PhD notified MRI Interventions, Inc. (the "Company") of his decision to resign as a member of the Company's Board of Directors (the "Board") effective as of December 31, 2013. Dr. Malernee also serves as a member of the Board's Audit Committee and Corporate Governance and Nominating Committee. Having served as a director of the Company since March 2010, Dr. Malernee elected to step down from the Board simply to give a new director candidate, Maria Sainz, who has extensive management and operations experience in the medical device industry, the opportunity to serve as a member of the Board. Accordingly, Dr. Malernee's resignation was not the result of any disagreement with the Company, its management or its operations, policies or practices.
from last CC:
We have previously stated that if we need additional funds to get our ClearPoint neuro business to break-even, our plan would be to obtain the funding through debt, and not so equity as we do not want the additional dilution at the current stock price, reiterate that position again on this call
#1 most advanced innovation in surgery application LIVE MRI
#2 Five of the 10 best hospitals in the nation already use the product
#3 NASDAQ listing maybe near
#4 market cap less than $100 millions, could go $billions
#5 Business accelerating
#6 acquisition target
#7 directors buying all the time
#8 tax loss selling to end
#9 BIG FISH will play this one sooner or later